Latest Options News

nib Group has announced a 5.47% average increase in health insurance premiums for 2026, citing rising hospital costs and increased claims. The insurer highlights efforts to ease out-of-pocket expenses and support chronic illness management amid sector-wide pressures.

BPH Energy Ltd reported a half-year net loss of $925,691, weighed down by investment write-downs and associate losses, while raising $1.2 million to fund exploration and development. The company’s future hinges on a Federal Court review of a critical offshore permit held by investee Advent Energy.

Carnavale Resources has retracted and replaced its recent investor presentation to correct overstated financial forecasts for gold prices above AUD 6,500/oz, reaffirming robust economics for its Kookynie Gold Project.

King River Resources has secured an exclusive option to acquire the Mindoolah Gold Project in Western Australia, boasting historic high-grade gold production and significant unmined mineralisation. The company plans an aggressive 2026 exploration campaign to unlock the project's substantial potential.

3D Energi has announced two significant gas discoveries in the Otway Basin, validating its exploration models and advancing regulatory approvals. The company is now considering a follow-up well that could unlock further value in the region.

Cycliq Group Limited reported a 27% revenue decline for the half-year ending December 2025 but managed to return to profitability amid strategic platform upgrades and steady customer engagement.

Stavely Minerals has locked in a $500,000 unsecured director loan facility to fund its 2026 Scoping Study targeting copper, gold, and silver production. This non-dilutive funding move underscores confidence from within the board as the company advances key projects.

Nexalis Therapeutics has completed a key capital raising milestone, issuing new shares, options, and performance rights following shareholder approval. This move supports the company’s clinical-stage drug development programs targeting pain and mental health.

TZ Limited clarifies its debt repayment timeline and progresses trade finance arrangements to support growing Microsoft-related sales, while highlighting its innovative AI-driven security technology.

Clever Culture Systems posted a $1.32 million loss for the half year ending December 2025, reflecting a strategic shift and reduced government grants. Despite this, the company strengthened its cash position, repaid government debt, and grew its APAS Independence instrument footprint globally.

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.

Botanix Pharmaceuticals has secured approximately A$45 million through a two-tranche placement and an underwritten security purchase plan to fund API purchases, derisk its supply chain, and accelerate growth of its flagship product Sofdra.